loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2243837 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    CIPHER PHARMS INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 EFLORNITHINE HYDROCHLORIDE (1)

    filter

    01 CIPHER PHARMACEUTICALS INC (1)

    filter

    01 CREAM (1)

    filter

    01 13.9%/W/W (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Canada
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Eflornithine Hydrochloride

      PDF Supplier PDF
      URL Supplier Web Content
      CREAM
      13.9%/W/W
      VANIQA
      Canada
      2243837
      30G
      Prescription
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 2243837

      Looking for CTD TGA MCC DOSSIER APPLICATION 2243837 1

      19

      CIPHER PHARMS INC, based in Canada, is a pharmaceutical company.

      One of their notable products is EFLORNITHINE HYDROCHLORIDE, with a corresponding application number 2243837 and regulatory information .

      proudly manufactured in the

      CIPHER PHARMS INC's VANIQA CREAM, medication with 13.9%/W/W of EFLORNITHINE HYDROCHLORIDE.

      Post Enquiry
      POST ENQUIRY